Protein arginine methyltransferase 6 enhances immune checkpoint blockade efficacy via the STING pathway in MMR-proficient colorectal cancer
Background The emergence of immunotherapy has revolutionized the paradigm of cancer treatment with immune checkpoint blockades (ICB) in solid cancers, including colorectal cancer (CRC). However, only a small subset of CRC patients harboring deficient mismatch repair (dMMR) or microsatellite instabil...
Saved in:
| Main Authors: | Tao Chen, Yu Zhang, Yang Sun, Ling Gao, Ting Lu, Jinlin Duan, Qiwei Li, Junyan Xue, Yonglong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/3/e010639.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Protein Arginine Methyltransferases in Inflammatory Responses
by: Ji Hye Kim, et al.
Published: (2016-01-01) -
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer
by: Ying Wu, et al.
Published: (2017-04-01) -
Regulation of protein arginine methyltransferase in osteoporosis: a narrative review
by: Ruiming Wen, et al.
Published: (2025-04-01) -
Targeted STING Activation Using Modified Ultrasound‐Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma
by: Sina Khorsandi, et al.
Published: (2025-06-01) -
Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
by: Zhu Xi, et al.
Published: (2024-02-01)